Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Anavex Life Sciences (AVXL) in Focus: Stock Rises 16.4%
Anavex Life Sciences Corp. (AVXL - Free Report) was a big mover last session, as its shares rose over 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company since Jun 2013, as the stock is now up 45.5%.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Anavex Life Sciences currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%
ANAVEX LIFE SCI Price
ANAVEX LIFE SCI Price | ANAVEX LIFE SCI Quote
A better-ranked Medical-Biomed/Gene stock is Innoviva, Inc. (INVA - Free Report) which sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>